BTCUSD Bitcoin

Victoria, Seychelles, December 27th, 2024, Chainwire

Bitget, the leading cryptocurrency exchange and Web3 company, has announced the pre-market launch of BIO Protocol (BIO), enabling users to trade BIO ahead of its official spot trading debut. This pre-market initiative offers a streamlined environment for buyers and sellers to engage in trading before the token’s spot listing, ensuring early access and liquidity for participants.

The pre-market trading period for BIO/USDT will run from 25th December 2024, 09:00 (UTC) to 3rd January 2025, 09:30 (UTC). Following this, spot trading will commence at 10:00 (UTC) on 3rd January 2025, with settlement deliveries beginning at 11:00 (UTC) and concluding by 15:00 (UTC) on the same day.

Users can access pre-market trading for BIO/USDT via the designated link.

Bitget’s pre-market trading platform supports two transparent and efficient settlement methods, ensuring users can participate with confidence:

• Coin Settlement: From the delivery start time, the system periodically executes deliveries, matching sell orders with adequate token balances to corresponding buy orders. For sell orders lacking sufficient tokens, settlements or compensation are processed by the delivery end time.
• USDT Settlement: Orders are settled at the delivery end time, using the average index price from the last ten minutes as the execution price, providing fairness and clarity.

These settlement mechanisms reflect Bitget’s commitment to offering a secure and transparent trading environment for all users.

BIO Protocol is an innovative network accelerating biotech advancements by enabling early-stage funding for scientific ventures. Designed to empower patients, scientists, and biotech builders, the protocol facilitates the collective funding, building, and ownership of tokenized biotech portfolios. By converging funding, incentives, and liquidity, BIO Protocol is fostering the development of an on-chain scientific economy, transforming the biotech landscape.

The launch of BIO Protocol (BIO) on Bitget’s pre-market platform underscores the exchange’s mission to provide access to emerging, high-impact projects that align with technological and economic innovation.

More details on BIO Protocol (BIO) and pre-market trading, users can find here.

About Bitget

Established in 2018, Bitget is the world's leading cryptocurrency exchange and Web3 company. Serving over 45 million users in 150+ countries and regions, the Bitget exchange is committed to helping users trade smarter with its pioneering copy trading feature and other trading solutions, while offering real-time access to Bitcoin price, Ethereum price, and other cryptocurrency prices. Formerly known as BitKeep, Bitget Wallet is a world-class multi-chain crypto wallet that offers an array of comprehensive Web3 solutions and features including wallet functionality, token swap, NFT Marketplace, DApp browser, and more.

Bitget is at the forefront of driving crypto adoption through strategic partnerships, such as its role as the Official Crypto Partner of the World's Top Football League, LALIGA, in EASTERN, SEA and LATAM markets, as well as a global partner of Turkish National athletes Buse Tosun Çavuşoğlu (Wrestling world champion), Samet Gümüş (Boxing gold medalist) and İlkin Aydın (Volleyball national team), to inspire the global community to embrace the future of cryptocurrency.

For more information, visit: Website | Twitter | Telegram | LinkedIn | Discord | Bitget Wallet

For media inquiries, please contact: media@bitget.com

Risk Warning: Digital asset prices are subject to fluctuation and may experience significant volatility. Investors are advised to only allocate funds they can afford to lose. The value of any investment may be impacted, and there is a possibility that financial objectives may not be met, nor the principal investment recovered. Independent financial advice should always be sought, and personal financial experience and standing carefully considered. Past performance is not a reliable indicator of future results. Bitget accepts no liability for any potential losses incurred. Nothing contained herein should be construed as financial advice. For further information, please refer to the Terms of Use.

Contact